Alnylam Pharmaceuticals
ALNY
#584
Rank
A$52.73 B
Marketcap
$410.79
Share price
-0.89%
Change (1 day)
50.23%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Cash on Hand

Cash on Hand as of June 2024 : A$3.93 B

According to Alnylam Pharmaceuticals 's latest financial reports the company has A$3.93 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Alnylam Pharmaceuticals - Cash on Hand chart (from 2003 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$3.58 B11.13%
2022-12-31A$3.22 B-3.82%
2021-12-31A$3.34 B37.7%
2020-12-31A$2.43 B11.31%
2019-12-31A$2.18 B42.05%
2018-12-31A$1.53 B-28.96%
2017-12-31A$2.16 B149.04%
2016-12-31A$0.86 B-41.38%
2015-12-31A$1.48 B74.6%
2014-12-31A$0.84 B208.21%
2013-12-31A$0.27 B132.71%
2012-12-31A$0.11 B-17.04%
2011-12-31A$0.14 B-37.99%
2010-12-31A$0.23 B-26.81%
2009-12-31A$0.31 B-49.51%
2008-12-31A$0.62 B39.64%
2007-12-31A$0.44 B61.92%
2006-12-31A$0.27 B152.07%
2005-12-31A$0.10 B83.75%
2004-12-31A$59.5 M90.7%
2003-12-31A$31.2 M13.59%
2002-12-31A$27.47 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.65 B-83.45%๐Ÿ‡บ๐Ÿ‡ธ USA
A$14.71 B 273.73%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.19 B-44.36%๐Ÿ‡บ๐Ÿ‡ธ USA
A$60.85 M-98.45%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.14 B-96.40%๐Ÿ‡บ๐Ÿ‡ธ USA
A$12.65 B 221.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$10.92 B 177.53%๐Ÿ‡ซ๐Ÿ‡ท France
A$3.38 B-13.97%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel